StonvexLoading…
StonvexStonvexStonvexCore line items from CLMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.14B | $4.19B | $4.18B | $4.69B |
Operating Income | $108.70M | $8.10M | $267.20M | $131.90M |
Net Income | $-33.80M | $-222.00M | $48.10M | $-173.30M |
EPS (Diluted) | $-0.39 | $-2.67 | Not available | Not available |
Total Assets | $2.69B | $2.76B | $2.75B | Not available |
Total Liabilities | $3.18B | $3.22B | $3.00B | Not available |
Cash & Equivalents | $125.10M | $38.10M | $7.90M | $35.20M |
Free Cash Flow OCF − CapEx | $56.60M | $-123.10M | $-286.70M | $-435.60M |
Shares Outstanding | 86.78M | 85.95M | 80.08M | 79.34M |